Long-term effects of octreotide on pituitary gigantism: Its analgesic action on cluster headache

Endocrine Journal

Volumn 51, Issue 5, 2004, Pages 449-452

  Otsuka, Fumio ^a   Mizobuchi, Satoshi ^a   Ogura, Toshio ^a   Sato, Kenji ^a   Yokoyama, Masataka ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Headache; Octreotide; Opioid receptor; Pituitary gigantism; Visual analogue scale

Indexed keywords

GROWTH HORMONE; LIDOCAINE; MORPHINE; NALOXONE; OCTREOTIDE; THIOPENTAL;

ADRENALECTOMY; ADULT; ANALGESIC ACTIVITY; ARTICLE; CANCER SIZE; CASE REPORT; CLINICAL FEATURE; CLUSTER HEADACHE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENCY; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; INJECTION; MALE; PROVOCATION TEST; TACHYPHYLAXIS; TRANSSPHENOIDAL SURGERY; VISUAL ANALOG SCALE;

ADENOMA; ADULT; ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS, HORMONAL; CLUSTER HEADACHE; GIGANTISM; HUMANS; MALE; MORPHINE; OCTREOTIDE; PAIN MEASUREMENT; PITUITARY NEOPLASMS; SELF ADMINISTRATION;

EID: 8844231766     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.449     Document Type: Article

References (16)

1. von Werder K (1993) Somatostatin analogues in pituitary adenomas. Recent Results Cancer Res 129: 25-44.
2. Eugster EA, Pescovitz OH (1999) Gigantism. J Clin Endocrinol Metab 84: 4379-4384.
3. Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16: 87-101.
4. Charest L, Comtois R, Beauregard H, Serri O (1989) Growth hormone rebound after cessation of sms 201-995 treatment in acromegaly. Can J Neurol Sci 16: 442-445.
5. Popovic V, Paunovic VR, Micic D, Nesovic M, Kendereski A, Djordjevic P, Manojlovic D, Micic J (1988) The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly. Horm Metab Res 20: 250-251.
6. Williams G, Ball JA, Lawson RA, Joplin GF, Bloom SR, Maskill MR (1987) Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J (Clin Res Ed) 295: 247-248.
7. Musolino NR, Marino Junior R, Bronstein MD (1990) Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995. Clin J Pain 6: 243-245.
8. Schmidt K, Althoff PH, Harris AG, Prestele H, Schumm-Draeger PM, Usadel KH (1993) Analgesic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind study with long-term follow-up. Pain 53: 223-227.
9. Pascual J, Freijanes J, Berciano J, Pesquera C (1991) Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case report. Pain 47: 341-344.
10. Maurer R, Gaehwiler BH, Buescher HH, Hill RC, Roemer D (1982) Opiate antagonistic properties of an octapeptide somatostatin analog. Proc Natl Acad Sci USA 79: 4815-4817.
11. Otsuka F, Kageyama J, Ogura T, Makino H (1998) Cluster headache dependent upon octreotide injection. Headache 38: 629.
12. Paunovic VR, Popovic V (1989) The development of dependence to an octapeptide somatostatin analog: contribution to the study of somatostatin analgesia. Biol Psychiatry 26: 97-101.
13. May A, Lederbogen S, Diener HC (1994) Octreotide dependency and headache: a case report. Cephalalgia 14: 303-304.
14. Newman CB, Melmed S, Snyder PJ, Young WF, Boyajy LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF (1995) Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients - a clinical research center study. J Clin Endocrinol Metab 80: 2768-2775.
15. Wahid ST, Marbach P, Stolz B, Miller M, James RA, Ball SG (2002) Partial tachyphylaxis to somatostatin (SST) analogues in a patient with acromegaly: the role of SST receptor desensitisation and circulating antibodies to SST analogues. Eur J Endocrinol 146: 295-302.
16. Park C, Yang I, Woo J, Kim S, Kim J, Kim Y, Sohn S, Kim E, Lee M, Park H, Jung J, Park S (2004) Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: the relationship with endogenous srif activity and response to octreotide. Endocr J 51: 227-236.